Important for AD, frontal cortices of the TgCRND8 mouse, a model for AD (43), had lower levels of mature SREBP-2 compared with frontal cortices of age-matched wild-type mice at an early stage of disease progression (Fig. 1H, I). This evidence concerns the gene SREBF2 and Alzheimer disease.